ClinicalTrials.gg
CompletedNCT05584098qSOFAUpdated Sep 8, 2025

MEWS, qSOFA and Physiological Parameters Combination in the Emergency Room

An interventional study of qSOFA, MEWS and physiological parameters combination in Sepsis, sponsored by St. Martin De Porress Hospital. Completed at 2 sites in Taiwan. Per ClinicalTrials.gov, last updated 2025-09-08.

Sponsored by St. Martin De Porress Hospital · Not applicable, Interventional, and Screening

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Mar 2022, registered Oct 2022).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
950
Allocation
Not applicable
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 51 studies in Sepsis with a site in Taiwan — 4 open to participants now, 5 under way, none of them phase 3. Sepsis · Taiwan.

Enrollment
4th of 22
950 · median 151
Started
2022
with 1 other
No phase
9 of 51
1 open now
Registered
45th of 51
by date

Among the 51 studies in Sepsis with a site in Taiwan, this one is the 4th largest by enrollment of the 22 interventional ones that give a count, is one of 2 that started in 2022, is one of 9 with no phase, and was the 45th registered.

Sepsis

2,425 studies on the registry are indexed under Sepsis; 543 are open to participants now.

Browse Sepsis studies →

Open to participants now

4 of the 51 studies in Sepsis with a site in Taiwan are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 319 Sepsis studies recruiting now, 212 (66%) set no upper age limit and 52 (16%) stop at 75 or younger; 67 take children under 18; 43 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 51 studies in Sepsis with a site in Taiwan, or all of them as a file.
02

Study summary

In the development of sepsis treatment of recent years, the demand for medical manpower has increased significantly when patients with sepsis appear because of the expansion of medical care demand and shortened response time related to sepsis Due to the shortage of manpower, a more simple and easy-to-operate inspection method is adopted and artificial intelligence technology is used to assist in the evaluation.

The applicability of physiological indicators MEWS, qSOFA and physiological parameters combination as sepsis screening tools in emergency department (ED) and predicting sepsis outcome in the emergency department. When patients with sepsis appear, artificial intelligence technology is used to remind the physicians to respond and administer drugs as soon as possible.

This is a single-center retrospective study of a group of patients admitted to the emergency department. The medical records were reviewed, mainly based on the hospital site records and the existing vital signs of the patients. Attended a hospital emergency room between January 2020 and December 2022. Physiological numerical indicators MEWS and qSOFA were all scored to understand the distribution of sepsis.

Read the detailed description
  1. A single-center retrospective study of a cohort of patients admitted to the emergency department
  2. To see a doctor in the emergency department of the hospital between January 2020 and December 2022, review their medical records, and focus on the hospital's on-site records and the existing patient's vital signs.
  3. The physiological indicators MEWS and qSOFA were scored to understand the distribution of sepsis.
  4. Remind the doctor when a suspected sepsis patient appears under level 5 triage and use artificial intelligence technology to assist
  5. This study will explore the specific improvement practices and effects of improving the response of patients with sepsis when they see a doctor
  6. To analyze and evaluate the economics and benefits of this operation mode, improve the accuracy of emergency inspection of sepsis patients and improve the rationality of hospital manpower deployment
  7. Scheduled progress of the plan: Patients who visited the emergency department of the hospital between January 2020 and December 2022 were included in this study under investigation. This is a retrospective study, and patients are required to undergo necessary examinations according to their own conditions, without any interference from the study
03

Conditions studied

  • Sepsis

Browse trials for

Keywords

  • Sepsis
  • Modified Early Warning Score(MEWS)
  • quick Sequential Organ Failure Assessment(qSOFA)
  • emergency Medicine
  • physiological parameters combination
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • This is a single-center retrospective study of a group of patients admitted to the emergency department.

Exclusion criteria

Exclusion Criteria:

  • Patients with incomplete treatment clinical data, lack of information in medical records, trauma patients
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
950 participants (actual)

Study arms

  • Other
    qSOFA, MEWS and physiological parameters combination

    Modified Early Warning Score(MEWS), quick Sequential Organ Failure Assessment(qSOFA) and physiological parameters combination are used in prediction of occurrence of sepsis

    Other: qSOFA, MEWS and physiological parameters combination

Interventions

  • OtherqSOFA, MEWS and physiological parameters combination

    qSOFA ,MEWS and physiological parameters combination used in emergency medicine department could be helpful in the identification of the occurrence of sepsis

06

What researchers measure

Primary outcomes

  1. qSOFA used in emergency medicine department

    The qSOFA score is a simple score consisting of three items: respiratory rate (RR) ≥ 22 breaths per minute, altered mentation (Glasgow Coma Scale \[GCS\] \< 15), and systolic blood pressure (SBP) \< 100 mmHg and lowest score is 1 and highest is 3. The more score will show more severe disease. MEWS score:Description Risk of death or ICU admission \<3: patient in a stable condition, 3-4: Signs of respiratory failure. Consider higher level of care, ≥5: Patient in a critical condition. Higher level of care recommended

    Time frame: From date of randomization until the date of first documented progression assessed up to 36 months

  2. Modified Early Warning Score(MEWS) which quickly determine whether a particular patient needs increased medical attention

    MEWS score = Systolic blood pressure + Heart rate + Urine output + Respiratory rate + Temperature + AVPU. The lowest score is 0 and highest score is 14. The more score will show more severe disease. MEWS score:Description Risk of death or ICU admission \<3: patient in a stable condition, 3-4: Signs of respiratory failure. Consider higher level of care, ≥5: Patient in a critical condition. Higher level of care recommended

    Time frame: From date of randomization until the date of first documented progression assessed up to 36 months

  3. physiological parameters combination

    Shock Index (SI) = Heart Rate / Systolic Blood Pressure Age-Adjusted Shock Index (Age SI) = Age x Shock Index Respiratory-Adjusted Shock Index (RASI) = HR/SBP × (RR/10)

    Time frame: From date of randomization until the date of first documented progression assessed up to 36 months

07

Study locations

2 sites
  • St. Martin De Porres Hospital
    Chiayi City, 600046, Taiwan
  • St. Martin De Porres Hospital
    Chiayi City, 60069, Taiwan
08

References and documents

Individual participant data

Plan to share: No — The individual participant data (IPD) is not available to other researchers

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2022 to primary completion in Jun 2023, 14 months.

Of 303 non-industry interventional studies with no phase under Sepsis, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's 14 months is below that.

Counting every sponsor, half of 326 studies reached it within 22 months; a quarter within 11 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 7, 2022
First posted
Oct 18, 2022
StartActual
Mar 20, 2022
Primary completionActual
Jun 10, 2023
CompletionActual
Sep 30, 2023
Last update
Sep 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05584098
Lead sponsor
St. Martin De Porress Hospital
Responsible party
Chia-hsi Chen (attending physician,emergency medicine department, St. Martin De Porress Hospital) — Principal investigator
First posted
Oct 18, 2022
Start date
Mar 20, 2022
Primary completion
Jun 10, 2023
Completion
Sep 30, 2023
Last update
Sep 8, 2025

Study contacts

Chia-Hsi Chen, MD
principal investigator · Emergency Medicine Department of St. Martin De Porres Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion